ALB and infection: Both CRL1505 and MPL16 were capable of significantly reducing S. pneumoniae lung colonization and the concentrations of BAL albumin as well as avoiding the pathogen’s dissemination the into the blood when infection was produced 1, 5, or 7 days after the treatment with lactobacilli.